The hypothesis that the interactions between ECS and KP metabolites could have clinical implications started with the finding of positive associations among some of these metabolites, particularly 2-AG, with IL-6 registered in patients with some psychiatric disorders compared to volunteers without these psychiatric disorders. The gene discussed is IL6; the disease is psychiatric disorder.